Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release while Breastfeeding
What is Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release ?
Brief: PAIN RELIEVER
Is using Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release safe or dangerous while breastfeeding?
Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release Breastfeeding Analsys
Aspirin while Breastfeeding
Low RiskCAS Number: 50-78-2
Excreted in non-significant amount into breast milk. Reye’s Syndrome has never been reported due to ASA through breast milk. It is thought to be highly unlikely to occur after isolated or small doses like those used for treatment of thrombosis or anti-abortion therapy. At high maternal dose, one case (dubious) of salicylic intoxication in the neonatal period and another case of thrombocytopenia in an infant have been reported. Likelihood of hemolysis should be considered in those patients with G6PD-deficiency. WHO Model List of Essential Medication: compatible while breastfeeding when used occasionally or small dose for antithrombotic prophylaxis management.
Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release Breastfeeding Analsys - 2
Aspirin while Breastfeeding
CAS Number: 50-78-2
After aspirin ingestion, salicylic acid is excreted into breastmilk, with higher doses resulting in disproportionately higher milk levels. Long-term, high-dose maternal aspirin ingestion probably caused metabolic acidosis in one breastfed infant. Reye's syndrome is associated with aspirin administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breastmilk is unknown. An alternate drug is preferred over continuous high-dose, aspirin therapy. After daily low-dose aspiring (75 to 325 mg daily), no aspirin is excreted into breastmilk and salicylate levels are low. Daily low-dose aspirin therapy may be considered as an antiplatelet drug for use in breastfeeding women.[1][2][3].
I am nursing mother and I have already used Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release, what should I do?
Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release so you should inform him based on your convenience.
My doctor has prescribed me Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release, what should I do?
Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use
If I am using Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release, will my baby need extra monitoring?
Not much monitoring required while using Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release
Who can I talk to if I have questions about usage of Low Dose Miniprin Enteric Safety Coated | Aspirin Tablet, Delayed Release in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week